cyc 202 has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreoli, L; Benigni, A; Caroli, C; Gagliardini, E; Galbusera, M; Longaretti, L; Moioli, D; Remuzzi, G; Romagnani, P; Tincani, A; Zoja, C | 1 |
| Benigni, A; Casiraghi, F; Cavinato, RA; Conti, S; Corna, D; Remuzzi, G; Rottoli, D; Zoja, C | 1 |
2 other study(ies) available for cyc 202 and Libman-Sacks Disease
| Article | Year |
|---|---|
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus.
Topics: Animals; Biopsy; Cells, Cultured; Female; Gene Expression Regulation; Humans; Kidney Tubules, Proximal; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Nephritis, Interstitial; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine; Toll-Like Receptor 9 | 2007 |
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
Topics: Animals; Anti-Inflammatory Agents; Autoimmunity; B-Lymphocytes; Cell Proliferation; Cyclin-Dependent Kinases; Disease Models, Animal; Drug Therapy, Combination; Female; Glomerulonephritis; Longevity; Lupus Erythematosus, Systemic; Methylprednisolone; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Protein Kinase Inhibitors; Proteinuria; Purines; Roscovitine; T-Lymphocytes | 2007 |